Patents by Inventor Ciaran Regan

Ciaran Regan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Psycho-pharmaceuticals
    Patent number: 8461389
    Abstract: The invention provides a selective Sigma 1 or Dopamine D3 receptor agonist or a 5HT2c receptor ligand for use in the treatment of symptoms of anxiety and/or depression associated with an affective disorder and/or symptoms associated with cognitive impairment disorder. Particularly useful are diphenhydramine derivatives of Formula (I) and particularly (2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethyl-ethanamin) (Captodiamine).
    Type: Grant
    Filed: April 20, 2009
    Date of Patent: June 11, 2013
    Assignee: University College Dublin, National University of Ireland, Dublin
    Inventors: Ciaran Regan, Lisa Conboy, Shane Gannon
  • PSYCHO-PHARMACEUTICALS
    Publication number: 20110034562
    Abstract: The invention provides a selective Sigma 1 or Dopamine D3 receptor agonist or a 5HT2c receptor ligand for use in the treatment of symptoms of anxiety and/or depression associated with an affective disorder and/or symptoms associated with cognitive impairment disorder. Particularly useful are diphenhydramine derivatives of Formula (I) and particularly (2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethyl-ethanamin) (Captodiamine).
    Type: Application
    Filed: April 20, 2009
    Publication date: February 10, 2011
    Applicant: University College Dublin, National University of Ireland, Dublin
    Inventor: CIARAN REGAN
  • PSYCHO-PHARMACEUTICALS
    Publication number: 20110034565
    Abstract: The invention provides a compound for use in the treatment of symptoms associated with psychosis, schizophrenia, a cognitive impairment disorder, a mood disorder, a nervous system disorder and/or a behavioral disorder. The compound has the formula ? and is administered to a subject in need thereof in an effective amount. The compound Meparfynol (3-methylpent-1-yn-3-ol) has been found to be effective.
    Type: Application
    Filed: April 20, 2009
    Publication date: February 10, 2011
    Applicant: University College Dublin, National University of Ireland, Dublin
    Inventors: Ciaran Regan, Lisa Conboy, Shane Gannon
  • Novel Method
    Publication number: 20070270432
    Abstract: The present invention relates to a novel method of promoting neuronal growth within the central nervous system of a mammal and to compounds and pharmaceutical compositions for use in such a method.
    Type: Application
    Filed: February 4, 2003
    Publication date: November 22, 2007
    Inventors: James Hagan, Neil Upton, Andrew Foley, Helen Gallagher, Ciaran Regan
  • Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
    Patent number: 6436954
    Abstract: Benzo[b]quinolizidine and benzo[f]indolizidine derivatives are provided which are useful for the treatment of Alzheimer's disease, senile dementia or other conditions characterized by memory loss. Pharmaceutical compositions containing these compounds, and methods for their use, are also provided.
    Type: Grant
    Filed: March 14, 2001
    Date of Patent: August 20, 2002
    Assignees: American Biogenetic Sciences, Inc., University College Dublin
    Inventors: Jacob Szmuszkovicz, Ciaran Regan
  • Prophylactic or therapeutic agent for amnesia
    Patent number: 6281242
    Abstract: A medicament comprising as an active ingredient a compound represented by the following formula: R2—CH2CONH—R1 wherein R1 represents pyridyl group, a substituted pyridyl group, phenyl group, or a substituted phenyl group; and R2 represents a 2-oxo-1-phyrrolidinyl group which may be substituted (e.g., N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide), which is useful for preventive and/or therapeutic treatment of amnesia caused by, for example, an anesthetic agent for intravenous administration such as propofol.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: August 28, 2001
    Assignee: Daiichi Pharmaceutical Co., Ltd.
    Inventors: Ciaran Regan, David O'Gorman, Alan O'Connell, Tadashi Shiotani